Prevention of Anthracyclines and HER2 Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis.
Ioanna Myrto SotiropoulouNikolaos Manetas-StavrakakisChristos KourekAndrew V XanthopoulosDimitrios E MagouliotisGrigorios GiamouzisIoannis SkoularigisAlexandros BriasoulisPublished in: Cancers (2024)
Through this systematic review and meta-analysis, it was shown that there is a reduction in cardiotoxicity from either anthracyclines or HER2 inhibitors in patients receiving pharmacoprophylaxis.